E.D. Gel Receives FDA Approval

The Centers for Disease Control and Prevention estimates that 30 million American men are affected by erectile dysfunction (E.D.) – most commonly occurring among men over the age of 40 with the likelihood increasing in older age.   The condition is defined as the inability to attain or sustain an erection and is often the result of insufficient blood flow – something drugs like Viagra have been able to help address.  A new topical gel option, recently approved by the U.S. Food and Drug Administration, will be sold over the counter and claims to work within 10 minutes. 

According to a recent New York Time Well report, a new gel, brand named Eroxon, is the first topical treatment for erectile dysfunction to be approved for sale without a prescription.  The gel will be available over-the-counter and claims to work much faster than oral treatments which can take up to 30 minutes to provide results.  It is unknown when sales will begin in the United States, but Eroxon is already available without a prescription in the United Kingdom and the European Union. 

Although trials of the gel have yet to be published, early data suggests the product is safe and works using a cooling and warming effect that stimulates nerves in the penis, triggering greater blood flow.  

Men with underlying health conditions are more likely to develop erectile dysfunction.  Men with diabetes are three times as likely to have E.D. and the condition can also develop as a result of hypertension. Erectile dysfunction is considered an early indicator of both chronic illnesses, according to the Centers for Disease Control and Prevention.  Cancer treatment, smoking, alcohol consumption and sleep disorders can also contribute to the condition.   E.D. can also be a side effect of certain medications. 

Low testosterone levels and performance anxiety can also play a role in erectile dysfunction. It’s important for men experiencing E.D. to talk first with their doctor before seeking over-the-counter, prescription, or other treatment options to address any underlying health conditions that could affect blood flow.